Skip to main content

Naropin

NDC 63323-288 · Fresenius Kabi USA, LLC

FDA carries 3 listing records for this NDC; the most recent is shown.

Generic nameROPIVACAINE HYDROCHLORIDE
Dosage formINJECTION, SOLUTION
RouteEPIDURAL
Active ingredient(s)ROPIVACAINE HYDROCHLORIDE
Strength10 mg/mL
Pharmacologic classAmide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE]
Marketing categoryNDA

Packages

63323-288-29 — 25 VIAL, SINGLE-DOSE in 1 TRAY (63323-288-29) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-288-23)

63323-288-27 — 5 AMPULE in 1 BOX (63323-288-27) / 20 mL in 1 AMPULE (63323-288-25)

63323-288-10 — 5 AMPULE in 1 BOX (63323-288-10) / 10 mL in 1 AMPULE (63323-288-01)

63323-288-11 — 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-288-11) / 10 mL in 1 VIAL, SINGLE-DOSE (63323-288-03)

63323-288-20 — 5 AMPULE in 1 BOX (63323-288-20) / 20 mL in 1 AMPULE (63323-288-06)

63323-288-21 — 25 VIAL, SINGLE-DOSE in 1 CARTON (63323-288-21) / 20 mL in 1 VIAL, SINGLE-DOSE (63323-288-07)

Billed under HCPCS

J2795 — Injection, ropivacaine hydrochloride, 1 mg Medicare Part B payment limit (ASP + 6%): $0.04

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

55150-195 — Ropivacaine Hydrochloride, 55150-196 — Ropivacaine Hydrochloride, 55150-197 — Ropivacaine Hydrochloride, 55150-198 — Ropivacaine Hydrochloride, 55150-199 — Ropivacaine Hydrochloride, 55150-200 — Ropivacaine Hydrochloride, 55150-201 — Ropivacaine Hydrochloride, 63323-285 — ROPIVACAINE HYDROCHLORIDE, 63323-286 — ROPIVACAINE HYDROCHLORIDE, 63323-287 — ROPIVACAINE HYDROCHLORIDE, 65145-107 — Ropivacaine Hydrochloride, 65145-108 — Ropivacaine Hydrochloride, 65145-109 — Ropivacaine Hydrochloride, 65145-110 — Ropivacaine Hydrochloride, 65145-165 — Ropivacaine Hydrochloride, 65145-166 — Ropivacaine Hydrochloride, 65219-632 — Ropivacaine Hydrochloride, 67457-798 — ROPIVACAINE HYDROCHLORIDE, 67457-799 — ROPIVACAINE HYDROCHLORIDE, 68083-262 — Ropivacaine hydrochloride, +50 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels